10QSB/A

QUARTERLY REPORT

Company: GALECTIN THERAPEUTICS INC
Filed: April 16, 2002
Period of Report: June 30, 2001
Accession Number: 0000891554-02-002097

View Document ↗ View on SEC.gov ↗